ArticleInternational journal of pharmaceutics: X2026
Development and characterization of a topical ferrochelatase inhibitor nanoemulsion for choroidal neovascularization therapy.
Debadatta Mohapatra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.